Kuvardina Olga N, Herkt Stefanie, Meyer Annekarin, Schneider Lucas, Yillah Jasmin, Kohrs Nicole, Bonig Halvard, Seifried Erhard, Müller-Tidow Carsten, Lausen Jörn
Institute for Transfusion Medicine and Immunohematology, Johann-Wolfgang-Goethe University and German Red Cross Blood Service, Frankfurt am Main, Germany.
Georg-Speyer-Haus, Institute for Tumorbiology and experimental Therapy, Frankfurt, Germany.
Oncotarget. 2017 Apr 24;8(42):71685-71698. doi: 10.18632/oncotarget.17386. eCollection 2017 Sep 22.
Hematopoietic differentiation is controlled by key transcription factors, which regulate stem cell functions and differentiation. TAL1 is a central transcription factor for hematopoietic stem cell development in the embryo and for gene regulation during erythroid/megakaryocytic differentiation. Knowledge of the target genes controlled by a given transcription factor is important to understand its contribution to normal development and disease. To uncover direct target genes of TAL1 we used high affinity streptavidin/biotin-based chromatin precipitation (Strep-CP) followed by Strep-CP on ChIP analysis using ChIP promoter arrays. We identified 451 TAL1 target genes in K562 cells. Furthermore, we analysed the regulation of one of these genes, the catalytic subunit beta of protein kinase A (), during megakaryopoiesis of K562 and primary human CD34+ stem cell/progenitor cells. We found that TAL1 together with hematopoietic transcription factors RUNX1 and GATA1 binds to the promoter of the isoform 3 of (). During megakaryocytic differentiation a coactivator complex on the promoter, which includes WDR5 and p300, is replaced with a corepressor complex. In this manner, activating chromatin modifications are removed and expression of the isoform during megakaryocytic differentiation is reduced. Our data uncover a role of the TAL1 complex in controlling differential isoform expression of . These results reveal a novel function of TAL1, RUNX1 and GATA1 in the transcriptional control of protein kinase A activity, with implications for cellular signalling control during differentiation and disease.
造血分化受关键转录因子调控,这些转录因子调节干细胞功能和分化。TAL1是胚胎期造血干细胞发育以及红系/巨核系分化过程中基因调控的核心转录因子。了解特定转录因子所控制的靶基因对于理解其在正常发育和疾病中的作用至关重要。为了揭示TAL1的直接靶基因,我们使用了基于高亲和力链霉亲和素/生物素的染色质沉淀(Strep-CP),随后通过ChIP启动子阵列对ChIP分析进行Strep-CP。我们在K562细胞中鉴定出451个TAL1靶基因。此外,我们分析了其中一个基因——蛋白激酶A催化亚基β(PKA-Cβ)在K562细胞和原代人CD34+干细胞/祖细胞巨核细胞生成过程中的调控情况。我们发现TAL1与造血转录因子RUNX1和GATA1一起结合到PKA-Cβ同工型3的启动子上。在巨核细胞分化过程中,PKA-Cβ启动子上包括WDR5和p300的共激活复合物被一个共抑制复合物所取代。通过这种方式,激活染色质修饰被去除,巨核细胞分化过程中PKA-Cβ同工型的表达降低。我们的数据揭示了TAL1复合物在控制PKA-Cβ同工型差异表达中的作用。这些结果揭示了TAL1、RUNX1和GATA1在蛋白激酶A活性转录控制中的新功能,对分化和疾病过程中的细胞信号控制具有重要意义。